Back to BridgeBio Oncology Therapeutics, Inc.

BridgeBio Oncology Therapeutics, Inc.

Institutional holders · 13F as of Dec 31, 2025

57 holders

HolderValueShares% of shares
Persistent Asset Partners Ltd$107.5K8,5850.01%
CIBC Private Wealth Group LLC$62.6K5,0000.01%
BANK OF AMERICA CORP /DE$50.0K3,9900.00%
T. Rowe Price Associates, Inc.$10.1K803,1341.00%
Rockefeller Capital Management L.P.$8.8K7000.00%
WELLS FARGO & COMPANY/MN$3.8K3000.00%
Royal Bank of Canada$1.0K1540.00%
← PrevPage 2 of 2Next →